Centessa Pharmaceuticals Ratios (2022-2025) | CNTA

Ratios Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 3,627.87%3,913.07%2,810.41%1,989.88%2,133.77%1,997.43%1,632.19%1,388.83%1,485.37%1,707.37%1,640.91%4,448.53%-164.92%1,718.62%1,893.60%
EBIT Margin 3,547.87%4,138.78%2,550.88%1,888.47%2,084.31%1,919.14%1,582.41%1,368.79%1,427.05%1,741.78%1,814.82%3,008.47%-205.18%1,895.04%1,861.25%
EBITDA Margin 3,680.27%3,979.73%2,831.84%1,950.75%2,124.35%952.69%1,527.55%1,405.56%1,499.25%1,736.40%1,645.13%4,405.45%-188.49%1,762.38%1,864.43%
Operating Margin 3,547.87%4,138.78%2,550.88%1,888.47%2,084.31%1,919.14%1,582.41%1,368.79%1,427.05%1,741.78%1,814.82%3,008.47%-205.18%1,895.04%1,861.25%
Net Margin 3,633.20%3,911.74%2,803.07%1,959.74%2,162.64%1,015.76%1,520.98%1,433.35%1,504.39%1,735.29%1,664.69%4,490.88%-174.23%1,745.60%1,899.34%
FCF Margin 3,350.47%3,636.18%2,034.55%2,370.22%2,043.75%1,798.86%1,473.24%1,209.26%1,474.34%1,607.13%837.82%1,726.50%-381.64%778.50%2,025.81%
Efficiency
Assets Average 551.62M500.20M461.83M424.08M398.39M385.14M368.81M344.21M363.51M504.28M593.26M552.32M509.99M470.21M
Equity Average 450.10M396.48M354.55M314.71M284.93M268.00M247.82M225.70M251.06M393.05M450.34M393.90M365.58M323.25M
Invested Capital 480.15M420.04M372.92M336.17M293.26M276.61M259.39M236.24M215.16M286.96M499.14M510.49M495.50M454.46M411.39M
Asset Utilization Ratio -0.02-0.02-0.02-0.02-0.03-0.03-0.03-0.02-0.020.010.010.01
Leverage & Solvency
Interest Coverage Ratio -35.48-41.39-25.51-18.88-20.84-19.19-15.82-13.69-14.27-17.42-18.15-30.08-10.70-18.95-18.61
Debt to Equity 0.160.160.180.210.240.260.290.320.360.270.150.270.280.320.36
Debt Ratio 0.130.130.140.160.180.190.200.210.230.190.120.190.210.220.24
Equity Ratio 0.820.810.780.760.730.700.690.660.660.720.820.700.730.700.67
Times Interest Earned -35.48-41.39-25.51-18.88-20.84-19.19-15.82-13.69-14.27-17.42-18.15-30.08-10.70-18.95-18.61
Valuation
Enterprise Value -59.25M-36.09M-117.54M-100.40M19.37M341.22M348.86M520.58M768.00M952.76M1,722.92M1,732.68M1,355.00M1,505.03M3,005.07M
Market Capitalization 485.25M448.11M327.30M293.25M365.60M644.81M630.20M777.13M998.18M1,247.59M2,241.37M2,214.86M1,639.50M1,755.75M3,251.28M
Return Ratios
Return on Sales 29.71%26.15%19.36%16.50%15.25%13.72%15.48%15.84%23.37%-30.09%-32.54%-35.97%
Return on Capital Employed -0.50%-0.53%-0.51%-0.51%-0.52%-0.50%-0.46%-0.34%-0.38%-0.37%-0.43%-0.48%
Return on Invested Capital -0.60%-0.66%-0.57%-0.57%-0.59%-0.59%-0.62%
Return on Assets -0.47%-0.50%-0.43%-0.41%-0.41%-0.40%-0.43%-0.32%-0.40%-0.41%-0.45%-0.52%
Return on Equity -0.61%-0.67%-0.61%-0.59%-0.61%-0.61%-0.63%-0.41%-0.52%-0.57%-0.63%-0.75%